Olsson Shawn's Form 4 filing
LENZ Therapeutics, Inc. (LENZ) · filed Nov 19, 2025
- Accession no.
- 0002015796-25-000003
- Filed
- Nov 19, 2025
- Trade date
- Nov 17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $261.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Olsson ShawnCIK 0002015796 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $2.08 | +$20,800 | 14,733 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −4,212 | $25.74 | −$108,416.88 | 10,521 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −5,788 | $26.37 | −$152,629.56 | 4,733 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 53,241 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.